Corbus Pharmaceuticals Holding (CRBP) — Cash Flow Reinvestment Rate
Latest as of September 2021:
0.34x
Corbus Pharmaceuticals Holding (CRBP) has a Cash Flow Reinvestment Rate of 0.34x as of September 2021, reinvesting $290.50K (capex $7.70K plus investments $282.80K) from operating cash flow of $856.95K. Explore Corbus Pharmaceuticals Holding capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
0.34x
(Capex + Investments) / Operating CF
Total Reinvested
$290.50K
Capex + Investments
Operating Cash Flow
$856.95K
USD
Capital Expenditures
$7.70K
USD
Annual Cash Flow Reinvestment Rate for Corbus Pharmaceuticals Holding (None–None)
Year-by-year capital reinvestment analysis for Corbus Pharmaceuticals Holding. For live market cap and broader valuation context, see Corbus Pharmaceuticals Holding (CRBP) total market value.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow